Documentation Centre

 

 

  of 6 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Why do elevated HDL cholesterol concentrations not protect against cardiovascular disease? July 02, 2010 Why do elevated HDL cholesterol concentrations not protect against cardiovascular disease? Arnold von Eckardstein, MD Institute of Clinical Chemistry, University Hospital of Zurich and Center for Integrative Human Biology, University of Zurich, Zurich, Switzerland Expert Opinions
Video 1:40 min.
(8 MB)
What are the best therapeutic options to improve HDL functions? June 11, 2010 What are the best therapeutic options to improve HDL functions? Arnold von Eckardstein, MD Institute of Clinical Chemistry, University Hospital of Zurich and Center for Integrative Human Biology, University of Zurich, Zurich, Switzerland Expert Opinions
Video 1:08 min.
(6 MB)
What is the relationship between HDL and the endothelium? May 21, 2010 What is the relationship between HDL and the endothelium? Arnold von Eckardstein, MD Institute of Clinical Chemistry, University Hospital of Zurich and Center for Integrative Human Biology, University of Zurich, Zurich, Switzerland Expert Opinions
Video 1:12 min.
(6 MB)
Could you summarize the protective roles of HDL particles? Do high HDL levels confer greater protection? March 12, 2010 Could you summarize the protective roles of HDL particles? Do high HDL levels confer greater protection? Arnold von Eckardstein, MD Institute of Clinical Chemistry, University Hospital of Zurich and Center for Integrative Human Biology, University of Zurich, Zurich, Switzerland Expert Opinions
Video 1:19 min.
(5 MB)
Could there be a link between HDL and diabetes? December 18, 2009 Could there be a link between HDL and diabetes? Arnold von Eckardstein, MD Institute of Clinical Chemistry, University Hospital of Zurich and Center for Integrative Human Biology, University of Zurich, Zurich, Switzerland Expert Opinions
Video 1:23 min.
(5 MB)
Could you comment on the heterogeneity of risk in type 2 diabetic patients? October 16, 2009 Could you comment on the heterogeneity of risk in type 2 diabetic patients? Arnold von Eckardstein, MD Institute of Clinical Chemistry, University Hospital of Zurich and Center for Integrative Human Biology, University of Zurich, Zurich, Switzerland Expert Opinions
Video 1:03 min.
(4 MB)

  of 6 Next page

Go to page: of